Google Offers Genome Storage, Analysis

The Internet search giant joins a number of other companies offering cloud computing and genome storage.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ISTOCK, KALAWINFor about $25 a year, Google will store a human genome sequence in its Google Genomics cloud platform, which was designed to provide researcher a way to keep, share, and analyze genomic data. “We saw biologists moving from studying one genome at a time to studying millions,” David Glazer, the Google software engineer who led the effort, told MIT Technology Review. “The opportunity is how to apply breakthroughs in data technology to help with this transition.”

Earlier this year, Google announced that it had joined the Global Alliance for Genomics and Health, a big consortium of research organizations, to host public genomic data on its cloud platform. Already, 3,500 genomes have been uploaded to Google’s servers, according to the Review.

“Cancer genome clouds” is a central goal of such repositories, Sheila Reynolds, a research scientist at the Institute for Systems Biology in Seattle told the Review. “Not everyone has the ability to download a petabyte of data, or has the computing power to work on it.”

According to Genetic Engineering & Biotechnology News back in March, the programming interface of Google Genomics “allows users to focus on science rather than tech details such as servers and file formats; store genomic data ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies